Autonomic Nervous System Drugs: Cholinergic vs Adrenergic Side-by-Side for NCLEX-RN
A focused cluster guide on autonomic nervous system pharmacology for NCLEX-RN — cholinergic agonists, anticholinergics, adrenergic agonists, and beta-blockers — side-by-side with mechanism, indications, adverse effects, and the priority nursing actions for each class.
Learning Objectives
- ✓Distinguish sympathetic and parasympathetic effects across organ systems
- ✓Apply cholinergic and anticholinergic drug effects to clinical scenarios
- ✓Compare alpha and beta adrenergic agonists by receptor selectivity and clinical use
- ✓Recognize the priority nursing actions for each autonomic drug class
- ✓Match antidotes to the autonomic drug classes (atropine, pralidoxime, naloxone analogues)
1. Direct Answer: Why ANS Drugs Are Heavily Tested On NCLEX
The autonomic nervous system controls most non-skeletal-muscle functions — heart rate, blood pressure, GI motility, bladder emptying, pupil size, salivation, bronchodilation, and sweating. ANS drugs are used to manipulate any of these. NCLEX tests whether the candidate can predict the effect of a drug based on which branch (sympathetic or parasympathetic) and which receptor (alpha, beta1, beta2, muscarinic, nicotinic) it targets, recognize the predictable adverse effects, and apply the priority nursing action. The master framework: sympathetic = fight-or-flight (increased HR, dilated bronchi, dilated pupils, decreased GI motility, decreased salivation); parasympathetic = rest-and-digest (decreased HR, constricted bronchi, constricted pupils, increased GI motility, increased salivation). Cholinergic drugs (and anticholinesterases) mimic parasympathetic. Anticholinergics block parasympathetic, producing sympathetic-like effects. Adrenergic agonists mimic sympathetic. Beta-blockers block sympathetic, producing parasympathetic-like effects on the heart. Once this framework is clear, dozens of drugs become predictable rather than memorized.
Key Points
- •Sympathetic = fight-or-flight; parasympathetic = rest-and-digest
- •Cholinergic mimics parasympathetic; anticholinergic blocks it
- •Adrenergic mimics sympathetic; beta-blocker blocks it
- •Receptor subtype (alpha1, alpha2, beta1, beta2, muscarinic, nicotinic) determines specific effects
- •Predicting effects from receptors beats memorizing individual drugs
2. Cholinergic Agonists And Anticholinesterases
Cholinergic agonists directly activate muscarinic receptors. Anticholinesterases prevent breakdown of acetylcholine, raising synaptic ACh levels. Direct agonists (bethanechol, pilocarpine, carbachol). Bethanechol: urinary retention (post-op, neurogenic bladder). Pilocarpine: glaucoma (constricts pupils, improves aqueous outflow), dry mouth in Sjögren's. Adverse effects (mnemonic SLUDGE-M): Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis, Miosis. Bradycardia, bronchospasm, hypotension also possible. Anticholinesterases — reversible (neostigmine, pyridostigmine, donepezil). Neostigmine: reverse non-depolarizing neuromuscular blockers post-anesthesia, treat myasthenia gravis. Pyridostigmine: chronic myasthenia gravis. Donepezil: Alzheimer's (modest cognitive improvement). Same SLUDGE-M effects. Anticholinesterases — irreversible (organophosphates — nerve agents, some pesticides). Toxicity: severe SLUDGE-M plus muscle paralysis (from nicotinic effects at neuromuscular junction). Antidote: atropine (blocks muscarinic effects) + pralidoxime/2-PAM (regenerates acetylcholinesterase if given within hours). Myasthenia gravis crisis differentiation (heavily tested NCLEX point): - Myasthenic crisis (too little ACh): worsening weakness, often after stress/infection/missed dose. Tensilon (edrophonium) test improves symptoms. Treatment: more cholinergic medication. - Cholinergic crisis (too much ACh): weakness PLUS SLUDGE-M symptoms. Tensilon worsens symptoms. Treatment: hold cholinergic, give atropine. Priority nursing for cholinergic agents: monitor heart rate (bradycardia), GI activity (cramping, diarrhea), bladder/respiratory function. Atropine at bedside as antidote.
Key Points
- •Direct agonists: bethanechol (bladder), pilocarpine (glaucoma)
- •Reversible AChE inhibitors: neostigmine, pyridostigmine, donepezil
- •Irreversible AChE inhibitors: organophosphates — antidote atropine + pralidoxime
- •SLUDGE-M effects: Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis, Miosis
- •Myasthenic vs cholinergic crisis: edrophonium test differentiates
3. Anticholinergics (Antimuscarinics)
Anticholinergics block muscarinic receptors, producing sympathetic-like effects on most organs. Classic agents: atropine, scopolamine, ipratropium, tiotropium, oxybutynin, tolterodine, benztropine, glycopyrrolate, dicyclomine, tricyclic antidepressants, diphenhydramine, hydroxyzine, first-generation antipsychotics. Different agents target different sites: - Atropine: bradycardia (IV emergency), preoperative drying of secretions, organophosphate poisoning antidote - Scopolamine: motion sickness (transdermal patch) - Ipratropium, tiotropium: COPD bronchodilation (less than beta agonists, fewer cardiac effects) - Oxybutynin, tolterodine: overactive bladder - Benztropine: extrapyramidal symptoms from antipsychotics - Glycopyrrolate: secretions reduction (end-of-life care) Anticholinergic adverse effects (mnemonic 'red as a beet, dry as a bone, hot as a hare, blind as a bat, mad as a hatter, full as a flask'): - Red as a beet: flushing - Dry as a bone: decreased sweating, dry mucous membranes - Hot as a hare: hyperthermia (cannot sweat) - Blind as a bat: blurred vision (dilated pupils, decreased accommodation) - Mad as a hatter: confusion, delirium (especially elderly) - Full as a flask: urinary retention - Plus: tachycardia, constipation Elderly patients are highly susceptible to anticholinergic delirium. Beers Criteria flags many anticholinergic drugs as inappropriate in elderly (diphenhydramine, hydroxyzine, oxybutynin, TCAs). Cumulative anticholinergic burden across multiple drugs is a heavily-tested geriatric concept. Contraindications: narrow-angle glaucoma (anticholinergics dilate pupils, can precipitate acute angle-closure attack), benign prostatic hyperplasia (worsen urinary retention), paralytic ileus. Antidote for severe anticholinergic toxicity: physostigmine (a centrally-acting AChE inhibitor — reverses CNS effects). Used in poisoning emergencies; not routine.
Key Points
- •Atropine: bradycardia treatment, organophosphate antidote, preop drying
- •Beers criteria: many anticholinergics inappropriate in elderly (delirium risk)
- •Anticholinergic toxidrome mnemonic: red, dry, hot, blind, mad, full
- •Contraindications: glaucoma, BPH, paralytic ileus
- •Severe toxicity antidote: physostigmine (centrally-acting)
4. Adrenergic Agonists By Receptor Selectivity
Adrenergic agonists activate alpha and beta receptors. Specific effects depend on which receptor subtype is targeted. Receptor effects (memorize for NCLEX): - Alpha1: peripheral vasoconstriction (raises BP), pupil dilation (mydriasis), bladder neck contraction - Alpha2: presynaptic feedback inhibition (clonidine works here — lowers BP centrally), aqueous humor reduction - Beta1: increased HR, contractility, conduction velocity (mainly cardiac) - Beta2: bronchodilation, vasodilation in skeletal muscle, uterine relaxation, hepatic glycogenolysis Key drugs: - Epinephrine: alpha + beta1 + beta2 (everything). Used in anaphylaxis, cardiac arrest. Doses: 0.3-0.5 mg IM for anaphylaxis; 1 mg IV every 3-5 min in arrest. - Norepinephrine (Levophed): alpha + beta1 (mainly vasopressor for septic shock). 'Leave them dead' (the wrong way) — extravasation causes severe tissue necrosis. Central line preferred. - Dopamine: dose-dependent. Low (1-3 mcg/kg/min) renal dopamine receptors (vasodilates renal); mid (3-10) beta1 (increased contractility); high (>10) alpha (vasoconstriction). Used in cardiogenic shock. - Dobutamine: beta1 selective (positive inotropy without much vasoconstriction). Used in heart failure with low cardiac output. - Phenylephrine: alpha1 selective vasoconstrictor. Used in hypotension, nasal decongestion. - Pseudoephedrine: alpha1 indirect (nasal decongestion). OTC. - Albuterol: beta2 selective (bronchodilation). Used in asthma, COPD. Side effects: tachycardia, tremor (some beta1 spillover at high doses). - Salmeterol, formoterol: long-acting beta2 agonists (LABAs). Asthma maintenance (never monotherapy — combine with inhaled corticosteroid). - Terbutaline: beta2 with bronchodilation and uterine relaxation (off-label in preterm labor). - Clonidine: alpha2 central agonist (decreased sympathetic outflow). Used in hypertension, ADHD, opioid withdrawal. Never stop abruptly (rebound hypertension). Priority nursing: vasopressors (epi, norepi, dopamine) require central line preferred, infusion pump, frequent BP monitoring (every 5-15 min while titrating), and monitor for extravasation (phentolamine if it occurs). Beta2 agonists in asthma: assess effectiveness within 5 minutes; tremor and tachycardia expected; teach to use rescue albuterol no more than 2x weekly (otherwise control is inadequate, step up therapy).
Key Points
- •Alpha1: vasoconstriction; Beta1: cardiac stim; Beta2: bronchodilation
- •Epinephrine: anaphylaxis (0.3-0.5 mg IM) and cardiac arrest
- •Norepinephrine: septic shock vasopressor; extravasation = tissue necrosis
- •Dobutamine: beta1 inotrope for cardiogenic shock
- •Albuterol (SABA) for rescue; LABAs never monotherapy in asthma
5. Beta-Blockers: The Sympathetic Brake
Beta-blockers block beta receptors, reducing sympathetic effects on the heart and (for non-selectives) the lungs. Selectivity matters: - Cardioselective (β1): metoprolol, atenolol, bisoprolol, esmolol. Safer in asthma/COPD (though still relative — at high doses some β2 effect). - Non-selective (β1+β2): propranolol, nadolol, timolol. Contraindicated in asthma; can precipitate bronchospasm. - Alpha + beta: carvedilol, labetalol (alpha1 vasodilation + beta blockade). Used in heart failure (carvedilol) and hypertensive emergencies (labetalol). Less reflex tachycardia. Indications: hypertension, heart failure (carvedilol, metoprolol succinate, bisoprolol — only certain ones survive trials), post-MI (mortality benefit), angina, atrial fibrillation rate control, migraine prophylaxis, anxiety/performance. Adverse effects: bradycardia, fatigue, decreased exercise tolerance, sexual dysfunction, masked hypoglycemia (especially in diabetics — beta-blocker hides the tremor/tachycardia signs of low blood sugar, leaving only sweating). Bronchospasm with non-selectives. Hold parameters (universally tested): hold beta-blocker if HR <60 or SBP <90. Inform provider. Discontinuation: NEVER stop abruptly after chronic use. Rebound tachycardia, hypertension, and increased MI risk. Taper over 1-2 weeks. Beta-blocker overdose: bradycardia, hypotension, hypoglycemia. Antidote: glucagon (bypasses beta receptor, raises cAMP directly). Atropine usually inadequate. IV calcium and high-dose insulin/dextrose are adjuncts in severe cases. Contraindications: severe asthma (non-selectives), decompensated heart failure (use carefully even with HF-indicated beta-blockers), AV block (>1st degree), severe peripheral vascular disease (worsens claudication). Priority nursing: assess HR and BP before each dose; teach not to stop abruptly; for diabetics, teach to monitor blood sugar more frequently and watch for sweating (the only retained hypoglycemia sign); assess exercise tolerance and report decreased capacity (decompensated HF).
Key Points
- •Cardioselective (metoprolol, atenolol): safer in asthma; still relative
- •Non-selective (propranolol): contraindicated in asthma (bronchospasm)
- •Hold if HR <60 or SBP <90
- •Never stop abruptly: rebound tachycardia, HTN, MI risk
- •Overdose antidote: glucagon (bypasses receptor)
6. Side-by-Side: Cholinergic vs Anticholinergic vs Adrenergic vs Beta-Blocker
The 4-class comparison table NCLEX wants you to internalize: | Effect | Cholinergic (PNS+) | Anticholinergic (PNS−) | Adrenergic (SNS+) | Beta-blocker (SNS−) | |---|---|---|---|---| | Heart rate | Decreased | Increased | Increased (β1) | Decreased | | Blood pressure | Decreased | Slight increase | Increased (α1) | Decreased | | Pupils | Constricted (miosis) | Dilated (mydriasis) | Dilated (α1) | No effect | | Bronchi | Constricted | Dilated | Dilated (β2) | Constricted (non-sel) | | GI motility | Increased | Decreased | Decreased | Increased | | Salivation | Increased | Decreased | Decreased | Slight increase | | Bladder | Empties | Retention | Retention (α1) | Slight increased emptying | | Sweating | Increased (PNS exception) | Decreased | Increased (β2, eccrine) | No major effect | Note the asymmetries: anticholinergic + adrenergic both increase heart rate but through different mechanisms. Beta-blocker + cholinergic both decrease heart rate. The organ-system question pattern on NCLEX: given a drug class and a patient situation, predict the effect on that organ system. Memorizing the table by row (organ system) makes prediction near-automatic. Classic NCLEX traps: - Asthma + non-selective beta-blocker → bronchospasm (avoid) - Glaucoma + anticholinergic → angle-closure attack (avoid) - BPH + anticholinergic → urinary retention (avoid) - Diabetes + beta-blocker → masked hypoglycemia (caution and teaching) - Bradycardia + beta-blocker → hold and notify - Hypotension + epinephrine extravasation → tissue necrosis (phentolamine if it happens)
Key Points
- •Cholinergic vs anticholinergic: opposite on every organ system
- •Adrenergic vs beta-blocker: opposite on heart specifically (not bronchi)
- •Bronchi: cholinergic constricts, anticholinergic dilates, beta2 agonist dilates, non-sel beta-blocker constricts
- •Pupils: anticholinergic + adrenergic both dilate (different mechanisms)
- •Classic NCLEX traps: asthma + non-sel BB; glaucoma + anticholinergic; BPH + anticholinergic
7. Priority Antidotes And Emergency Protocols
ANS drug emergencies appear frequently on NCLEX. Memorize antidote pairs: | Toxidrome | Antidote | |---|---| | Cholinergic crisis / organophosphate poisoning | Atropine (muscarinic effects) + pralidoxime (regenerates AChE) | | Anticholinergic toxicity (severe) | Physostigmine | | Beta-blocker overdose | Glucagon (high-dose) | | Calcium channel blocker overdose | Calcium IV, glucagon, high-dose insulin + dextrose | | Vasopressor extravasation (norepi, dopamine) | Phentolamine (local infiltration) | | Opioid overdose | Naloxone (Narcan) | | Benzodiazepine overdose | Flumazenil (rarely used due to seizure risk) | | Heparin overdose | Protamine | | Warfarin overdose | Vitamin K (slow), PCC/FFP (fast) | | Acetaminophen overdose | N-acetylcysteine (NAC) | Anaphylaxis protocol (universal): 1. Epinephrine 0.3-0.5 mg IM (deltoid or thigh — thigh preferred for rapid absorption). Repeat every 5-15 min as needed. 2. IV fluids (large bore, run wide open). 3. Diphenhydramine 25-50 mg IV/IM (H1 blocker). 4. Famotidine 20 mg IV (H2 blocker for combined H1+H2 blockade). 5. Methylprednisolone 125 mg IV (prevents biphasic reaction at 4-12 hours). 6. Bronchodilator (albuterol nebulizer) if wheezing. 7. Vasopressor if persistent hypotension despite epi + fluids. 8. Monitor in ED for at least 4-8 hours (biphasic reaction risk). Position: anaphylaxis with hypotension → supine with legs elevated; difficulty breathing → semi-fowler. Discharge teaching: epinephrine auto-injector prescription, two carried at all times, allergen avoidance, medical-alert bracelet. Cardiac arrest meds (ACLS basics): epinephrine 1 mg IV q3-5 min (any rhythm); amiodarone 300 mg IV (VF/pulseless VT). Atropine 0.5 mg IV q3-5 min for symptomatic bradycardia (max 3 mg).
Key Points
- •Anaphylaxis: epinephrine 0.3-0.5 mg IM is FIRST (before everything else)
- •Organophosphate: atropine + pralidoxime
- •Beta-blocker overdose: glucagon
- •Vasopressor extravasation: phentolamine local infiltration
- •Acetaminophen overdose: NAC
8. How NurseIQ Helps With ANS Pharmacology
Autonomic pharmacology is the densest receptor-based content area in NCLEX-RN. The trick is mastering the receptor-organ table once and applying it to any drug. Snap a photo of any ANS pharmacology question and NurseIQ identifies the drug class, applies the receptor-effect table to the patient situation, and produces the priority intervention or teaching point. For crisis differentiation (myasthenic vs cholinergic, anaphylaxis sequencing, vasopressor selection in shock), NurseIQ walks through the decision tree step by step. This content is for educational purposes only and supports nursing student learning.
Key Points
- •Applies receptor-effect table to specific patient situations
- •Differentiates myasthenic vs cholinergic crisis using clinical cues
- •Walks through anaphylaxis sequencing in order
- •Generates scenario-based practice for high-yield NCLEX traps
- •Useful for NCLEX-RN, NCLEX-PN, and nursing pharmacology coursework
High-Yield Facts
- ★Sympathetic = fight-or-flight; parasympathetic = rest-and-digest
- ★Alpha1: vasoconstriction. Beta1: cardiac stim. Beta2: bronchodilation
- ★Cholinergic SLUDGE-M: Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis, Miosis
- ★Anticholinergic toxidrome: red, dry, hot, blind, mad, full
- ★Atropine: bradycardia treatment AND organophosphate antidote
- ★Pralidoxime: regenerates AChE; must be given within hours of organophosphate exposure
- ★Cardioselective β1 (metoprolol, atenolol) safer in asthma; non-selective (propranolol) avoid
- ★Beta-blocker overdose antidote: glucagon
- ★Anaphylaxis FIRST step: epinephrine 0.3-0.5 mg IM (NEVER subcutaneous, NEVER IV first)
- ★Hold beta-blocker if HR <60 or SBP <90
- ★Norepinephrine extravasation → tissue necrosis → phentolamine antidote
- ★Beers Criteria: many anticholinergics inappropriate in elderly (delirium risk)
Practice Questions
1. A patient with COPD asks why ipratropium works better than albuterol for them. What is the best explanation?
2. A patient on metoprolol becomes diaphoretic and confused but does not have tremors or tachycardia. Blood sugar is 50 mg/dL. Why are tremors and tachycardia absent?
3. A patient with myasthenia gravis on pyridostigmine presents with worsening weakness AND diarrhea/cramping. What is the most likely problem and intervention?
4. A farmer is brought to ED after pesticide exposure. He has miosis, drooling, diarrhea, and respiratory distress. Action?
5. A patient with anaphylaxis receives IM epinephrine but remains hypotensive after 10 minutes. Next action?
6. A patient newly started on tamsulosin (an alpha1 blocker for BPH) reports dizziness on standing. Teaching?
FAQs
Common questions about this topic
Pupil size is controlled by two muscles. The sphincter pupillae (constrictor) is parasympathetically innervated via muscarinic receptors. Cholinergic activation → constriction (miosis). Anticholinergic blockade → unopposed sympathetic dilator pupillae action → dilation (mydriasis). This is why anticholinergics are dangerous in narrow-angle glaucoma (mydriasis can precipitate acute angle closure).
Alpha1 receptors are postsynaptic on vascular smooth muscle. Activation = vasoconstriction (raised BP). Alpha2 receptors are presynaptic (autoreceptor) on sympathetic nerve endings. Activation = feedback inhibition of further norepinephrine release. Clonidine is an alpha2 agonist — it lowers BP CENTRALLY by reducing sympathetic outflow. Confusingly, this means an alpha agonist (clonidine) LOWERS blood pressure, while another alpha agonist (phenylephrine, alpha1) RAISES it. The receptor subtype determines the effect direction.
Dopamine activates different receptors at different concentrations. At low doses (1-3 mcg/kg/min), it preferentially binds DA1 receptors in renal/mesenteric vasculature, producing vasodilation and improving renal blood flow. At medium doses (3-10), beta1 effects predominate, increasing cardiac contractility. At high doses (>10), alpha effects appear, causing systemic vasoconstriction. This makes dopamine versatile but also tricky to titrate; many clinicians prefer drugs with clearer receptor profiles (dobutamine for inotropy, norepinephrine for vasoconstriction).
IM injection in the deltoid or anterolateral thigh produces a more controlled, sustained rise in blood epinephrine levels with a lower risk of arrhythmia and hypertensive crisis. IV epinephrine produces an immediate, brief spike that can cause ventricular arrhythmias, severe hypertension, and myocardial ischemia. IV is reserved for cardiac arrest (where these risks are accepted) or for vasopressor infusion (slow drip with continuous monitoring). The reflex 'epinephrine IM first' captures this safety principle. Subcutaneous is too slow for anaphylaxis.
Yes. Snap a photo of any ANS pharmacology question and NurseIQ identifies the drug class, applies the receptor-effect table to the specific patient situation, and produces the priority intervention or teaching point. For crisis differentiation (myasthenic vs cholinergic), antidote selection (atropine + pralidoxime for organophosphate, glucagon for beta-blocker overdose), and anaphylaxis sequencing, NurseIQ walks through the decision tree. This content is for educational purposes only and supports nursing student learning.